It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

Colossal Biosciences raises $200M in Series C funding led by TWG Global, advancing its innovative de-extinction projects and ...

Anges Inc. has entered into a sponsored research agreement with Stanford University School of Medicine for the development of novel cancer therapies using genome editing technology. The parties aim to ...

A group of scientists says they will bring back the woolly mammoth by late 2028, and they just announced that they raised ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

The de-extinction company led by CEO Ben Lamm has raked in $435 million in funding since its launch. He believes it has ...

The White House is honoring three Iowa State researchers for their work in artificial intelligence, genome editing and ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...

EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MGX), a precision genetic medicines company committed to ...

Colossal Biosciences, the world's first de-extinction company, has today announced $200M in a Series C financing by TWG ...